Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Circle Internet Group Inc. Class A Common Stock (CRCL) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Circle Internet Group Inc. Class A Common StockTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Circle Internet Group Inc. Class A Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Circle Internet Group Inc. Class A Common Stock trades at $82.22 (market cap $20.52B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Circle Internet Group Inc. Class A Common Stock is far larger — about 5.2× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Circle Internet Group Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Circle Internet Group Inc. Class A Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

CRCLRLAY
Market Cap
$20.52B$3.94B
Volume
8,829,0813,432,928
Sector
FinancialsHealth
52-Week High
$150.48$20.75
52-Week Low
$50.23$6.03
Typical Hold Time
0 Days0 Days
Enterprise Value
$19.03B$3.06B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRCL
100% Buy0% Sell
Avg holding period · 0 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About Circle Internet Group Inc. Class A Common Stock

Circle Internet Group provides internet financial infrastructure centered on its stablecoin network. Its business includes stablecoins, blockchain infrastructure for developers, digital-asset services, and payment applications.

Read more on CRCL →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →